The commission upheld a previous ruling by a US judge who ruled in Masimo’s favor. The patent in question is for light-based pulse oximetry technology or blood oxygen tracking on Apple Watches. While ITC’s latest ruling confirms Apple’s infringement and can potentially stop the company from bringing Apple Watches to the US, it will not come into effect immediately. The decision now faces a Presidential review and could be followed by possible appeals by Apple.
The Biden administration will have 60 days to veto the import ban on Apple Watches. However, as Reuters notes, US Presidents have rarely vetoed bans in the past. It’s unclear which models of the Apple Watch could be affected by the ban if it comes into effect. However, Masimo’s complaint alleged that the Apple Watch 6, the first one to feature blood oxygen tracking, violated its patent.
“Masimo has wrongly attempted to use the ITC to keep a potentially lifesaving product from millions of U.S. consumers while making way for their own watch that copies Apple,” an Apple spokesperson told Reuters. “While today’s decision has no immediate impact on sales of Apple Watch, we believe it should be reversed, and will continue our efforts to appeal.”
Meanwhile, Masimo CEO Joe Kiani said the ITC’s ruling “sends a powerful message that even the world’s largest company is not above the law.”
Originally Posted at https://slashdot.org/